Germany has a high demand in meniscal allograft transplantation but is subject to health economic and legal challenges: a survey of the German Knee Society - Report - MDSpire

Germany has a high demand in meniscal allograft transplantation but is subject to health economic and legal challenges: a survey of the German Knee Society

  • By

  • Philipp W. Winkler

  • Svea Faber

  • Maurice Balke

  • Sebastian Metzlaff

  • Thomas R. Niethammer

  • Philip P. Roessler

  • Ralf Henkelmann

  • Alexander Kurme

  • Sebastian Colcuc

  • Gerald Zimmermann

  • Wolf Petersen

  • Theresa A. Diermeier

  • January 31, 2022

  • 0 min

Share

High Demand for Meniscal Allograft Transplantation in Germany Faces Economic and Legal Hurdles

Overview

A survey among German Knee Society members revealed a high clinical demand for meniscal allograft transplantation (MAT) in Germany despite limited availability. Key barriers include reimbursement issues, legal restrictions on donor graft use, and graft availability, which hinder timely MAT implementation.

Background

Meniscal preservation is critical to prevent early osteoarthritis, yet many meniscal tears remain irreparable, necessitating meniscal resection. Patients with meniscus deficiency often suffer from pain and reduced function, for which MAT is a viable treatment to improve symptoms and quality of life. However, in Germany, legal and economic challenges restrict access to meniscal allografts, prompting investigation into the current status and demand for MAT.

Data Highlights

Survey ParameterValue
Total respondents152
Respondents from Germany136 (89.5%)
Board certified specialized knee surgeons87 (57.2%)
Participants performing >100 meniscal surgeries annually83 (54.6%)
Participants considering MAT clinically necessary139 (91.5%)
Participants considering MAT in ≥5 patients annually90 (59.2%)
Participants who have performed MAT54 (35.5%)
Types of meniscal allografts usedFresh-frozen 56.6%, PAA sterilized 35.9%, Cryopreserved 7.6%
Techniques used for MATArthroscopic 54.7%, Arthroscopically assisted 41.5%, Open 3.8%
Main challenges reportedReimbursement 82.9%, Legal jurisdiction 77.6%, Graft availability 76.3%

Key Findings

  • 91.5% of respondents agree MAT is clinically necessary in Germany.
  • More than half of participants perform over 100 meniscal surgeries annually.
  • Only 35.5% have performed MAT, with most performing fewer than 5 procedures.
  • Fresh-frozen grafts are the most commonly used meniscal allografts.
  • Reimbursement issues, legal restrictions on donor graft use, and graft availability are the primary barriers to MAT.
  • When MAT is not feasible, alternatives include lower limb realignment, physical therapy, unicompartmental knee arthroplasty, and artificial meniscal implants.

Clinical Implications

Clinicians should recognize the high demand for MAT in Germany and advocate for improved access to meniscal allografts. Awareness of legal and reimbursement barriers is essential to navigate treatment options effectively. Alternative treatments should be considered when MAT is not available, but efforts to overcome systemic hurdles are critical to optimize patient outcomes.

Conclusion

Despite strong clinical demand for meniscal allograft transplantation in Germany, economic and legal challenges significantly limit its availability and use. Addressing these barriers is necessary to integrate MAT more fully into routine knee preservation strategies.

References

  1. German Knee Society Survey 2021 -- High Demand for Meniscal Allograft Transplantation in Germany

Original Source(s)

Related Content